Clinical Management of Diabetes and Complications
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Endocrinology".
Deadline for manuscript submissions: 25 March 2026 | Viewed by 77
Special Issue Editors
Interests: obesity; diabetes mellitus; MAFLD; renal failure; metabolic syndrome; prediabetes; atherosclerosis; metabolic inflammation; insulin resistance
Special Issues, Collections and Topics in MDPI journals
Interests: type 2 diabetes mellitus; obesity; insulin resistance; atherosclerosis; cardiovascular risk; metabolic syndrome; diabetes technology; cardiorenal–metabolic interactions; diabetes complications; digital health; diabetes education
Special Issue Information
Dear Colleagues,
The clinical management of diabetes and its complications represents a central challenge in contemporary medicine, requiring continuous adaptation to emerging therapies, comorbidities, and patient needs. This Special Issue, “Clinical Management of Diabetes and Complications”, aims to provide a comprehensive overview of current clinical strategies and emerging therapeutic options in the management of diabetes and its associated complications.
This Special Issue will address advances in pharmacological treatment—including novel antidiabetic agents with proven cardiorenal–metabolic benefits—as well as lifestyle and digital interventions for glycaemic and complication control. Particular focus will be given to the early recognition and individualized management of diabetic complications such as cardiovascular disease, nephropathy, neuropathy, retinopathy, and diabetic foot syndrome.
We will also explore comorbid conditions closely linked to the pathophysiology of diabetes, such as obesity and metabolic dysfunction-associated fatty liver disease (MAFLD), which play growing roles in cardiovascular as well as metabolic risk assessment and therapeutic decision making. In addition, contributions on diabetes remission—through nutritional interventions, bariatric surgery, or pharmacotherapy—are encouraged, reflecting a paradigm shift in the long-term management of type 2 diabetes.
We welcome papers exploring innovative care models, structured education programs, and integrated multidisciplinary approaches, with the aim to improve the outcomes and quality of life of people living with diabetes. Additionally, the use of artificial intelligence, continuous glucose monitoring systems, insulin delivery devices, remote monitoring, and precision medicine in diabetes care will be considered as priorities.
Original research articles, clinical trials, systematic reviews, and expert perspectives contributing to the optimization of care in diabetes and its complications are invited. This Special Issue welcomes submissions from both clinical and translational researchers for evidence-based, patient-centred approaches.
Dr. Anca Pantea Stoian
Guest Editor
Dr. Delia V. Reurean-Pintilei
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetic complications’ multidisciplinary management
- MAFLD
- diabetes remission
- cardiovascular risk
- precision medicine
- antidiabetic therapy
- diabetes mellitus
- digital health
- chronic disease management
- obesity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
